- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
Systemic absorption of miconazole in children is very low or below the limit of detection (which is < 1 ng/ml)
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Skin infections by dermatophytes or Candida species |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
The likelihood of local and systemic effects increases with use in children and with prolonged use: use under occlusion and use on large surfaces
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Be careful when using in children (thinner skin) because of the increased risk of systemic side effects. Use in children can rapidly cause adrenal cortex suppression and also growth hormone suppression. The safety and efficacy of hydrocortisone in children aged < 1 month have not been established.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Antibiotics | ||
|---|---|---|
| D01AA01 | ||
| Imidazole and triazole derivatives | ||
|---|---|---|
| D01AC01 | ||
| D01AC08 | ||
| D01AC02 | ||
| D01AC09 | ||
| Other antifungals for topical use | ||
|---|---|---|
| D01AE14 | ||
| D01AE13 | ||
| D01AE15 | ||
| IMIDAZOLE AND TRIAZOLE DERIVATIVES | ||
|---|---|---|
| D01AC01 | ||
| D01AC08 | ||
| D01AC02 | ||
| D01AC09 | ||
| OTHER ANTIFUNGALS FOR TOPICAL USE | ||
|---|---|---|
| D01AE14 | ||
| D01AE13 | ||
| D01AE15 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Reference
- Janssen-Cilag BV, SmPC Daktacort (RVG 07342) 14-09-2018, www.geneesmiddeleninformatiebank.nl
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
